Table 3.
ALSPAC | QIMR | Meta-analysis | |
---|---|---|---|
All individuals | |||
N = 5328 | N = 498 | N = 5826 | |
Mean | 0.014 (0.016), P = 0.19 | 0.040 (0.052), P = 0.22 | 0.016 (0.015), P = 0.14 |
High | 0.012 (0.015), P = 0.21 | 0.014 (0.046), P = 0.38 | 0.012 (0.014), P = 0.20 |
Low | 0.013 (0.016), P = 0.21 | 0.041 (0.057), P = 0.24 | 0.015 (0.015), P = 0.16 |
Male | |||
N = 2615 | N = 231 | N = 2846 | |
Mean | −0.002 (0.020), P = 0.54 | −0.099 (0.083), P = 0.88 | −0.007 (0.019), P = 0.65 |
Female | |||
N = 2713 | N = 287 | N = 3000 | |
Mean | 0.046 (0.028), P = 0.05 | 0.125 (0.072), P = 0.04 | 0.056 (0.026), P = 0.02 |
High | 0.030 (0.025), P = 0.12 | 0.068 (0.058), P = 0.12 | 0.036 (0.023), P = 0.06 |
Low | 0.040 (0.026), P = 0.06 | 0.112 (0.082), P = 0.09 | 0.047 (0.025), P = 0.03 |
Displayed are beta (SE) and P-values in each of the cohorts and the combined estimates from the fixed effects, inverse-variance weighted meta-analysis. ‘Mean’ refers to analyses involving the average CAG repeat length, ‘High’ refers to analyses involving the highest length repeat and ‘Low’ refers to analyses involving the lower length repeat. One-tailed P-values testing for a positive association between CAG repeat length and 2D:4D ratio are presented.